Biomedical Papers - Epub Ahead of Print

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | 10.5507/bp.2014.003

Unstable angina pectoris prior to ST elevation myocardial infarction in patients treated with primary percutaneous coronary intervention has no influence on prognosis

Krystyna Kluza,b, Jiri Parenicac,d, Lenka Kubkovaa,c,d, Simona Littnerovae, Josef Tomandla, Martin Poloczekc, Ondrej Tomanc, Martin Tesakc,f, Zdenka Cermakovag, Jana Gottwaldovag, Jan Manousekc, Monika Pavkova Goldbergovaa, Jindrich Spinara,c,d, Jiri Jarkovskye
a Department of Internal Cardiology, Medical Faculty, Masaryk University, Brno, Czech Republic
b Hospital Podlesi a.s., Trinec
c Department of Cardiology, Faculty Hospital Brno
d Department of Cardiovascular Disease, International Clinical Research Center, St. Anne´s University Hospital in Brno
e Institute of Biostatistics and Analyses, Masaryk University, Brno
f Hospital Trebic, Trebic-Jejkov
g Department of Biochemistry, Faculty Hospital Brno

Background: Pre-infarction unstable angina pectoris (UAP) can be considered ischemic preconditioning. The aim of this study was to compare short and long term outcomes in patients with or without pre-infarction UAP and ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).

Methods: 593 patients with STEMI (388 without and 205 with UAP) were evaluated. Levels of biomarkers (troponin I, BNP, NT-ProBNP, neopterin, endoglin and pentraxin-3) at hospital admission and 24 h after STEMI onset were assessed. Echocardiography was undertaken on the fourth day after MI and after 12 months. The median follow-up was 37 months.

Results: We found no significant differences in sex, age or risk factors for atherosclerosis between the UAP and non-UAP group. As the median time from the onset of chest pain to admission was significantly longer in the UAP group (228 min vs 258 min; P=0.009), we used a propensity score to obtain comparable matched groups for use in further analyses. The levels of NT-proBNP were significantly higher on admission and after 24 hours in the UAP group. Left ventricular functions according to invasive and echocardiographic parameters were entirely comparable at hospitalization and after 12 months. No differences were found in severity index of acute heart failure during hospitalization. The incidence of major acute coronary events during follow-up was comparable for the groups.

Conclusions: In patients with STEMI treated with primary PCI, pre-infarction UAP has no beneficial clinical effect during hospitalization or during long-term follow-up.

Keywords: pre-infarction angina pectoris, STEMI, primary PCI, natriuretic peptides

Received: August 8, 2013; Accepted: January 14, 2014; Published: January 23, 2014


References

  1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74(5):1124-36. Go to original source... Go to PubMed...
  2. Rajesh KG, Sasaguri S, Zhitian Z, Suzuki R, Asakai R, Maeda H. Second Windows of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression. Cardiovasc Res 2003;59(2):297-307. Go to original source... Go to PubMed...
  3. Wang L, Cherednichenko G, Hernandez L, Halow J, Camacho SA, Figueredo V, Schaefer S. Preconditioning limits mitochondrial Ca(2+) during ischemia in rat hearts: role of K(ATP) channels. Am J Physiol Heart Circ Physiol 2001;280(5):H2321-8.
  4. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996;334(1):7-12. Go to original source... Go to PubMed...
  5. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 1995;91(2):291-7. Go to original source... Go to PubMed...
  6. Shiraki H, Yoshikawa T, Anzai T, Negishi K, Takahashi T, Asakura Y, Akaishi M, Mitamura H, Ogawa S. Association between preinfarction angina and a lower risk of right ventricular infarction. N Engl J Med 1998;338(14):941-7. Go to original source... Go to PubMed...
  7. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, Ueda K. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis. J Am Coll Cardiol 1997;30(4):970-5. Go to original source... Go to PubMed...
  8. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991;84(1):350-6. Go to original source...
  9. Kositprapa C, Ockaili RA, Kukreja RC. Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart. J Mol Cell Cardiol 2001;33(7):1355-62. Go to original source... Go to PubMed...
  10. Rorabaugh BR, Ross SA, Gaivin RJ, Papay RS, McCune DF, Simpson PC, Perez DM. α1A- but not α1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism. Cardiovasc Res 2005;65(2):436-445. doi: 10.1016/j.cardiores.2004.10.009. Go to original source... Go to PubMed...
  11. Tong H, Bernstein D, Murphy E, Steenbergen C. The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J 2005;19(8):983-5. Go to original source...
  12. Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268(5 Pt 2):H2157-61. Go to PubMed...
  13. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266(3 Pt 2):H1145-52. Go to PubMed...
  14. Lochner A, Genade S, Tromp E, Podzuweit T, Moolman JA. Ischemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation 1999;100(9):958-66. Go to original source... Go to PubMed...
  15. Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res 2001;88(2):175-80. Go to original source... Go to PubMed...
  16. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 2005;15(2):69-75. Review. Go to original source... Go to PubMed...
  17. Miura T, Tanno M, Sato T. Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc Res 2010;88(1):7-15. Review. Go to original source... Go to PubMed...
  18. Costa AD, Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol 2008;295(2):H874-82. doi: 10.1152/ajpheart.01189.2007 Go to original source...
  19. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transitiv pore opening during myocardial reperfusion- a target for cardioprotection. Cardiovasc Res 2004;61(3):372-85. Review. Go to original source... Go to PubMed...
  20. Bishopric NH, Andreka P, Slepak T, Webster KA. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol 2001;1(2):141-50. Review. Go to original source... Go to PubMed...
  21. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 2011;301(5):H1723-41. doi: 10.1152/ajpheart.00553.2011 Go to original source... Go to PubMed...
  22. Richard V, Kaeffer N, Tron C, Thuillez C. Ischemic preconditioning proteus against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation 1994;89(3):1254-61. Go to original source... Go to PubMed...
  23. Bahr RD, Leino EV, Christenson RH. Prodromal unstable angina in acute myocardial infarction: prognostic value of short- and long-term outcome and predictor of infarct size. Am Heart J 2000;140(1):126-33. Go to original source... Go to PubMed...
  24. Lee CW, Hong MK, Lee JH, Yang HS, Kim JJ, Park SW, Park SJ. Determinants and prognostic significance of spontaneous coronary recanalization in acute myocardial infarction. Am J Cardiol 2001;87(8):951-4; A3. Go to original source...
  25. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, Mitsuba N, Kisaka T, Nakama H, Kijima Y. Comparison of the cardioprotective effect of prodromal angina pectoris and collateral circulation in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 2005;95(5):622-5. Go to original source... Go to PubMed...
  26. Billinger M, Fleisch M, Eberli FR, Garachemani A, Meier B, Seiler C. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J Am Coll Cardiol 1999;33(4):1027-35. Go to original source... Go to PubMed...
  27. Tomoda H, Aoki N. Comparison of protective effects of preinfarction angina pectoris in acute myocardial infarction treated by thrombolysis versus by primary coronary angioplasty with stenting. Am J Cardiol 1999;84(6):621-5. Go to original source... Go to PubMed...
  28. Papadopoulos CE, Zioutas DG, Giannakoulas GA, Matsiras S, Karamitsos TD, Karvounis HI, Geleris P, Stiliadis I. Beneficial effect of ischemic preconditioning on post-infarction left ventricular remodeling and global left ventricular function. Cardiovasc Revasc Med 2011;12(5):286-91. doi: 10.1016/j.carrev.2010.11.005 Go to original source... Go to PubMed...
  29. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, Ueda K. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis. J Am Coll Cardiol 1997;30(4):970-5. Go to original source... Go to PubMed...
  30. Przyklenk K, Whittaker P. Brief antecedent ischemia enhances recombinant tissue plasminogen activator-induced coronary thrombolysis by adenosine-mediated mechanism. Circulation 2000;102(1):88-95. Go to original source... Go to PubMed...
  31. Iglesias-Garriz I, Fernandez-Vazquez F, Perez A, Jimenez-Bonilla J, Garrote C, Uriarte P, Delafuente C. Preinfarction angina limits myocardial infarction size in nondiabetic patients treated with primary coronary angioplasty. Chest 2005;127(4):1116-21. Go to original source... Go to PubMed...
  32. Tomoda H, Aoki N. Coronary blood flow in evolving myocardial infarction preceded by preinfarction angina: a critical reevaluation of preconditioning effects in clinical cases. Angiology 2004;55(1):9-15. Go to original source... Go to PubMed...
  33. Zahn R, Schiele R, Schneider S, Gitt AK, Seidl K, Bossaller C, Schuler G, Gottwik M, Altmann E, Rosahl W, Senges J. Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry). Am J Cardiol 2001;87(1):1-6. Go to original source...
  34. Kala P, Miklik R. Pharmaco-mechanic antithrombotic strategies to reperfusion of the infarct-related artery in patients with ST-elevation acute myocardial infarctions. J Cardiovasc Transl Res 2013;6(3):378-87. doi:10.1007/s12265-013-9448-1 Go to original source... Go to PubMed...
  35. Ottani F, Galli M, Zerboni S, Galvani M. Prodromal angina limits infarct size in the setting of acute anterior myocardial infarction treated with primary percutaneous intervention. J Am Coll Cardiol 2005;45(9):1545-7. Go to original source... Go to PubMed...
  36. Tomoda H, Aoki N. Comparison of protective effects of preinfarction angina pectoris in acute myocardial infarction treated by thrombolysis versus by primary coronary angioplasty with stenting. Am J Cardiol 1999;84(6):621-5. Go to original source... Go to PubMed...
  37. De Luca G, Parodi G, Sciagra R, Bellandi B, Comito V, Vergara R, Migliorini A, Valenti R, Antoniucci D. Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty. Atherosclerosis 2013;226(1):153-6. doi: 10.1016/j.atherosclerosis.2012.09.008 Go to original source...
  38. Lorgis L, Gudjoncik A, Richard C, Mock L, Buffet P, Brunel P, Janin-Manificat L, Beer JC, Brunet D, Touzery C, Rochette L, Cottin Y, Zeller M. Pre-infarction angina and outcomes in non-ST-segment elevation myocardial infarction: data from the RICO survey. PLoS One 2012;7(12):e48513. doi: 10.1371/journal.pone.0048513 Go to original source...
  39. Banerjee S, Tang XL, Qiu Y, Takano H, Manchikalapudi S, Dawn B, Shirk G, Bolli R. Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. Am J Physiol 1999;277(6 Pt 2):H2488-94.
  40. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 2001;103(24):2935-41. Go to original source... Go to PubMed...
  41. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y, Yamaguchi M, Hori R, Yasue H, Nakao K. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995;92(6):1558-64. Go to original source... Go to PubMed...
  42. Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, Braunwald E. Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J 2011;32(11):1390-7. doi:10.1093/eurheartj/ehr032 Go to original source... Go to PubMed...
  43. Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, Braunwald E. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 2007;115(24):3071-8. Go to original source... Go to PubMed...
  44. Cruz-Gonzalez I, Pabon P, Rodriguez-Barbero A, Martin-Moreiras J, Pericacho M, Sanchez PL, Ramirez V, Sanchez-Ledesma M, Martin-Herrero F, Jimenez-Candil J, Maree AO, Sanchez-Rodriguez A, Martin-Luengo C, Lopez-Novoa JM. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction. J Cell Mol Med 2008;12(3):955-61. doi: 10.1111/j.1582-4934.2008.00156.x Go to original source... Go to PubMed...
  45. Knoflach M, Kiechl S, Mantovani A, Cuccovillo I, Bottazzi B, Xu Q, Xiao Q, Gasperi A, Mayr A, Kehrer M, Willeit J, Wick G. Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies. PLoS One 2012;7(2):e31474. doi: 10.1371/journal.pone.0031474 Go to original source... Go to PubMed...
  46. Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A; Lipid Assessment Trial Italian Network (LATIN) Investigators. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004;110(16):2349-54. Go to original source... Go to PubMed...